SOX2 and neoplasm: Besides, SOX2 was reported to be associated with early tumor initiation (Robinson et al., 2021), and its level in high-grade serous carcinoma (HGSC) effusions was demonstrated to be markers of clinically aggressive disease (Sherman-Samis et al., 2019).